Page 180 - ASHG 2013 Program Guide

POSTER SESSIONS
  167
POSTER SESSIONS
W=W
ednesday authors will present; T=Thursday authors will present; F=Friday authors will pr
esent
1284
T Genome-wide association study of alcohol
consumption in the Kaiser Permanente/UCSF Genetic
Epidemiology Research on Adult Health and Aging
Cohort.
E. Jorgenson, L. Shen, T. Hoffmann, M. Kvale, Y.
Banda, D. Ranatunga, N. Risch, C. Schaefer, C. Weisner,
J. Mertens.
1285
F Transethnic genome-wide meta-analysis of
Alzheimer disease in Alzheimer’s Disease Genetics
Consortium.
G. Jun, J. Chung, J. Kozubek, C. Reitz,
B. N. Vardarajan, K. L. Lunetta, J. L. Haines, M. A.
Pericak-Vance, R. Kuwano, R. Mayeux, G. D.
Schellenberg, L. A. Farrer, Alzheimer’s Disease
Genetics Consortium.
1286
W Pathway-based polygenic scores and variation
explained by functional SNPs in schizophrenia.
K. K.
Nicodemus, G. Donohoe, D. Tropea, D. Morris, K. Kendler,
F. O’Neill, D. Walsh, B. Riley, M. Gill, A. Corvin, Wellcome
Trust Case Control Consortium 2.
1287
T Meta analysis identifies
TSNARE1
as novel
schizophrenia/bipolar susceptibility locus.
P. Sleiman,
D. Wang, J. Glessner, D. Hadley, R. E. Gur, N. Cohen,
Q. Li, H. Hakonarson, Janssen-CHOP Neuropsychiatric
Genomics Working Group.
1288
F Psychiatric Genomics Consortium quadruples
schizophrenia GWAS sample-size to 35,000 cases
and 47,000 controls.
S. Ripke, Schizophrenia Group of
Psychiatric Genomics Consortium.
1289
W Polymorphisms in the
CACNA1C
gene region
and amygdala activation during encoding of negative
emotional stimuli.
L. Gschwind, C. Vogler, D. Coynel,
A. Milnik, V. Freytag, K. Spalek, D. de Quervain, A.
Papassotiropoulos.
1290
T Genetic variation underlying amygdala-volume
is highly enriched with schizophrenia susceptibility
variants in healthy young individuals.
P. Lee, A. Holmes,
P. Gallagher, L. Germine, M. Hollinshead, J. Roffman, R.
Buckner, J. Smoller.
1291
F Brain N-acetylaspartate is Increased in mouse
models of Pelizaeus-Merzbacher disease: Implication
for human imaging findings
K. Inoue, Y. Itoh, S. Saito, I.
Aoki, J. Barkovich, J. Takanashi.
1292
W
SZT2
mutations in infantile encephalopathy
with epilepsy and callosal dysgenesis.
L. Basel-
Vanagaite, T. Hershkovitz, E. Heyman, M. Raspall-Chaure,
N. Kakar, P. Smirin-Yosef, M. Vila-Pueyo, L. Korenreich,
H. Thiele, H. Bode, I. Lagovsky, D. Dahary, A. Haviv, M.
Pasmanik-Chor, P. Nürnberg, C. Kubisch, M. Shohat, A.
Macaya, G. Borck.
1293
T Association between Alzheimer’s genetic risk
scores and hippocampal and amygdala volume.
M. K.
Lupton, W. Wen, K. Mather, H. Brodaty, D. Ames, J. N.
Trollor, N. J. Armstrong, A. Simmons, S. Lovestone, J. F.
Powell, P. S. Sachdev, M. J. Wright, GERAD1 Consortium,
Addneuromed Consortium, Alzheimer’s Disease
Neuroimaging Initiative.
1273
F A genome-wide association study of the
response to cognitive behavioral therapy in children
with anxiety disorders.
J. R. I. Coleman, K. Lester,
C. Curtis, J. L. Hudson, C. Creswell, G. Breen, T. C. Eley.
1274
W Genome-wide association study of shared
components of reading disability and language
impairment.
J. D. Eicher, N. R. Powers, L. L. Miller, S. M.
Ring, J. R. Gruen, Pediatric Imaging, Neurocognition, and
Genetics Study.
1275
T A genome-wide association between migraine in
bipolar disorder and neurobeachin.
K. K. Jacobsen, S.
Johansson, C. M. Nievergelt, T. Zayats, T. A. Greenwood,
H. S. Akiskal, J. Haavik, O. B. Fasmer, J. R. Kelsoe, K. J.
Oedegaard, BiGS Consortium.
1276
F Genome-wide association study of
HLA-
DQB1*06:02
negative essential hypersomnia.
S. S. Khor,
T. Miyagawa, H. Toyoda, M. Yamasaki, Y. Kawamura, H.
Tanii, Y. Okazaki, T. Sasaki, L. Lin, J. Faraco, T. Rico, Y.
Honda, M. Honda, E. Mignot, K. Tokunaga.
1277
W Genome-wide association study and admixture
mapping of age-related cognitive decline in African
Americans.
T. Raj, L. B. Chibnik, C. McCabe, B. Stranger,
H. Hendrie, L. Barnes, T. Foroud, J. M. Murrell, D. A.
Bennett, K. S. Hall, D. A. Evans, P. L. De Jager.
1278
T Genome-wide association study of growth rate
and energy status in lymphoblastoid cell lines.
A. R.
Sanders, W. Moy, H. H. H. Göring, J. Freda, D. He, S. L.
Fuentes, J. Duan, P. V. Gejman, Molecular Genetics of
Schizophrenia (MGS) Collaboration.
1279
F Distinct genetic contributions to Tourette
syndrome and obsessive compulsive disorder as
revealed by cross-disorder genome-wide studies.
D.
Yu, on behalf of TS GWAS Consortium, TSAICG, and
IOCDFGC.
1280
W Coding variations and the risk of adult ADHD:
An exome-chip association study in adult ADHD from
the IMpACT.
T. Zayats, S. Johansson, J. Haavik, IMPACT
Consortium.
1281
T Genome-wide association study of rate of
cognitive decline in six Alzheimer’s disease cohorts.
R. Sherva, A. L. Gross, S. Mukherjee, S. Newhouse,
J. Kauwe, L. Munsie, A. J. Saykin, D. A. Bennett, L. B.
Chibnik, P. Kraft, P. K. Crane, R. C. Green, Alzheimer’s
Disease Neuroimaging Initiative and GENAROAD
Consortium.
1282
F Rare variant discovery in late-onset Alzheimer’s
disease using exome arrays.
L.-S. Wang, A. C. Naj,
C. Cruchaga, S. Mukherjee, R. Graham, B. Kunkle, A.
Partch, L. Cantwell, P. Crane, A. M. Goate, J. L. Haines, R.
Mayeux, L. Farrer, M. A. Pericak-Vance, T. Behrens, G. D.
Schellenberg, Alzheimer’s Disease Genetics Consortium.
1283
W A noise-reduction GWAS in multiple sclerosis.
J. P. Hussman, A. H. Beecham, M. Schmidt, J. L.
McCauley, J. L. Haines, M. A. Pericak-Vance, International
Multiple Sclerosis Genetics Consortium.